26 assets in Fibrotic Liver Disease

Therapeutic assets addressing Fibrotic Liver Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Entecavir Fibrotic Liver Disease	Tanta University	P4	BB (70)
Hydronidone Fibrotic Liver Disease	Beijing Continent Pharmaceutical Co, Ltd.	P3	BB (67)
Empagliflozin Fibrotic Liver Disease	Military University Hospital, Prague	P4	BB (65)
Ertugliflozin Fibrotic Liver Disease	Getz Pharma	P4	BB (65)
azd2389 Fibrotic Liver Disease	AstraZeneca	P2	BB (64)
Candesartan Fibrotic Liver Disease	Sherief Abd-Elsalam	P3	B (60)
Survodutide Fibrotic Liver Disease	Boehringer Ingelheim	P3	B (60)
Corpril Fibrotic Liver Disease	Sherief Abd-Elsalam	P3	B (58)
Rencofilstat Fibrotic Liver Disease	Hepion Pharmaceuticals, Inc.	P2	B (57)
Setanaxib Fibrotic Liver Disease	Calliditas Therapeutics Suisse SA	P2	B (57)
Simvastatin Fibrotic Liver Disease	Anna Cruceta	P2/3	B (57)
Vilagletistat Fibrotic Liver Disease	Dr. Falk Pharma GmbH	P2	B (57)
Atorvastatin Fibrotic Liver Disease	Raymond Chung	P2	CCC (53)
Multiple Vitamins Injection Fibrotic Liver Disease	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	P2	CCC (53)
Semaglutide Fibrotic Liver Disease	University of California, San Diego	P2	CCC (53)
Synthroid Fibrotic Liver Disease	VA Office of Research and Development	P2	CCC (53)
Zinc Sulfate Fibrotic Liver Disease	Tanta University	P2	CCC (53)
Dasatinib Fibrotic Liver Disease	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P1/2	CCC (50)
Flavone, 3,3',4',5,7-Pentahydroxy- Fibrotic Liver Disease	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P1/2	CCC (50)
Recombinant Humanised Igg1 Kappa Anti-Cldn1 Monoclonal Antibody Ale.F02 Fibrotic Liver Disease	Alentis Therapeutics AG	P1	CC (47)
Gallium-68 Labelled Fap-2286 Fibrotic Liver Disease	Thomas Hope	P1	CC (46)
Phin-214 Subcutaneous Fibrotic Liver Disease	PharmaIN	P1	CC (43)
Ganwei Fibrotic Liver Disease	Taipei City Hospital	N/A	D (30)
Metformin Fibrotic Liver Disease	Taipei City Hospital	N/A	D (30)
Sulfasalazine Fibrotic Liver Disease	The Second Affiliated Hospital of Chongqing Medical University	N/A	D (30)
Ursodeoxycholic Acid Fibrotic Liver Disease	The Second Affiliated Hospital of Chongqing Medical University	N/A	D (30)